Scoring methods for anti-PD therapy eligibility and compositions for performing same
US10613092B2 · kind B2 · utility
1Cited by
0References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 1, 2017 |
| Grant date | Apr 7, 2020 |
| Priority date | — |
| Expiry date | Sep 2, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Aspects of the present disclosure provide methods for determining the eligibility of a subject having a malignancy for treatment with an anti-PD therapeutic agent based on a Combined Positive Score (CPS) for a tumor tissue sample from the subject. Compositions and kits or performing the disclosed methods are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.